NCT01595984View on ClinicalTrials.gov

Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)

PHASE3UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 3, 2012

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Kidney Failure
Interventions
DRUG

cyclosporin + mycophenolate mofetil

antirejection drug, renal transplantation

DRUG

everolimus + mycophenolate mofetil

antirejection drug, renal transplantation

Trial Locations (2)

34285

Nephrology Department, University Hospital of Montpellier, Montpellier

80000

Nephrology department, Hospital University of Amiens, Amiens

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Centre Hospitalier Universitaire, Amiens

OTHER